Health Affairs: In Health Affairs: Large positive returns on HIV treatment
In an analysis examining the costs and achievements of antiretroviral therapy for people living with HIV, “Steven Forsythe of Avenir Health and coauthors evaluated data used by UNAIDS to calculate that in the period 1995-2015, antiretroviral therapy (ART) averted 9.5 million deaths worldwide, with global economic benefits of $1.05 trillion. The authors also found that for every $1 spent on ART, $3.50 in benefits was realized globally. Including future projections, the authors estimated that in 1995-2030, approximately 40.2 million new HIV infections could be averted …, with economic gains reaching $4.02 trillion in 2030. With different countries achieving different results for the different targets, the authors recommend analyses of national treatment program performance to enhance overall benefits and efficiency…” (7/1).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.